Abstract
Critical limb ischemia (CLI) is associated with increased risk of amputations, cardiovascular events and mortality. Antiplatelet therapy is a crucial component of CLI treatment. High on-treatment platelet reactivity (HPR), defined by a platelet reactivity unit (PRU) score above 208 on the VerifyNow
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
